Ninepoint Partners LP Acquires Shares of 4,728 Lam Research Corporation $LRCX

Ninepoint Partners LP acquired a new position in shares of Lam Research Corporation (NASDAQ:LRCX) during the 2nd quarter, Holdings Channel reports. The firm acquired 4,728 shares of the semiconductor company’s stock, valued at approximately $2,049,000.

A number of other institutional investors also recently made changes to their positions in the business. Fideuram Asset Management Ireland dac acquired a new stake in shares of Lam Research in the 4th quarter valued at about $10,035,000. Rokos Capital Management LLP grew its stake in Lam Research by 42.0% in the first quarter. Rokos Capital Management LLP now owns 259,921 shares of the semiconductor company’s stock worth $55,532,000 after purchasing an additional 76,840 shares in the last quarter. Aware Super Pty Ltd as trustee of Aware Super acquired a new position in Lam Research in the first quarter worth about $59,973,000. Krilogy Financial LLC increased its holdings in Lam Research by 19.5% in the first quarter. Krilogy Financial LLC now owns 28,111 shares of the semiconductor company’s stock valued at $6,006,000 after buying an additional 4,584 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd acquired a new stake in Lam Research during the first quarter valued at approximately $26,489,000. 84.61% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Lam Research news, Director Abhijit Y. Talwalkar sold 18,282 shares of the business’s stock in a transaction on Monday, July 13th. The stock was sold at an average price of $335.00, for a total transaction of $6,124,470.00. Following the completion of the transaction, the director owned 87,142 shares in the company, valued at approximately $29,192,570. The trade was a 17.34% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Eric Brandt sold 54,500 shares of the firm’s stock in a transaction on Thursday, June 11th. The shares were sold at an average price of $350.80, for a total value of $19,118,600.00. Following the transaction, the director directly owned 199,205 shares in the company, valued at $69,881,114. This trade represents a 21.48% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 80,441 shares of company stock worth $27,614,296. 0.31% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of research firms have commented on LRCX. Morgan Stanley reduced their target price on Lam Research from $404.00 to $367.00 and set an “overweight” rating on the stock in a report on Thursday, July 30th. Zacks Research raised Lam Research from a “hold” rating to a “strong-buy” rating in a research report on Friday, July 17th. UBS Group restated a “buy” rating and set a $375.00 price objective (up from $310.00) on shares of Lam Research in a research note on Tuesday, June 9th. Jefferies Financial Group set a $335.00 price objective on shares of Lam Research and gave the stock a “buy” rating in a report on Thursday, July 30th. Finally, TD Cowen reiterated a “buy” rating and set a $400.00 target price (up from $340.00) on shares of Lam Research in a research note on Thursday, July 9th. One research analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $358.47.

Lam Research Price Performance

NASDAQ LRCX opened at $310.17 on Tuesday. The company has a 50-day moving average price of $335.90 and a two-hundred day moving average price of $286.99. Lam Research Corporation has a 52 week low of $94.11 and a 52 week high of $438.50. The stock has a market cap of $388.12 billion, a price-to-earnings ratio of 53.85, a price-to-earnings-growth ratio of 1.25 and a beta of 1.84. The company has a current ratio of 2.63, a quick ratio of 1.91 and a debt-to-equity ratio of 0.30.

Lam Research (NASDAQ:LRCX) last released its quarterly earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share for the quarter, beating analysts’ consensus estimates of $1.69 by $0.13. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.The company had revenue of $6.72 billion for the quarter, compared to analysts’ expectations of $6.66 billion. During the same quarter in the previous year, the company posted $1.33 earnings per share. The business’s revenue for the quarter was up 30.0% compared to the same quarter last year. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. Analysts forecast that Lam Research Corporation will post 9.32 EPS for the current year.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.